# DeepCure

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/deepcure

- Industry: Biotechnology
- Headquarters: Boston, US
- Website: www.deepcure.ai
- Total disclosed funding: $65M
- Latest round: Series A (Apr 11, 2024)
- Investors on record: 6

## About

Based in Massachusetts, US, and co-founded by Kfir Schreiber (CEO), Joseph Jacobson (CSO), and Thrasyvoulos (Thras) Karydis (CTO) in 2018, DeepCure, Inc. operates as a Biotechnology research company offering an artificial intelligence (AI) based engine for the AI-driven small-molecule drugs development. In April 2024, the firm raised USD 24.6 million in series A funding led by investor IAG Capital Partners, along with the participation of other investors Benon Group Ltd., Morningside Venture Partners, Sapir Venture Partners, and TLV Partners.

The company through advanced technology optimizes all phases of drug discovery, from hit identification to lead optimization and beyond. The DeepCure’s portfolio includes Binding Modeling, PocketExpander™, and MolGen™, which enable the creation of precise, human-interpretable hypotheses, design of diverse compounds, and prediction of important pharmacological properties, across different therapeutic indications. DeepCure's approach ensures better molecules and faster cures, aiming to discover, develop, and deliver small-molecule drugs. Some of the products in the company’s pipeline include Brd4 for oral systemic, cutaneous, and ophthalmic indications, undisclosed transcription factors for inflammation or immune indications, etc.

The company plans to utilize the April 2024 funding for the development of its technology and to advance the clinical trials of immunology and inflammation drugs.

## Funding rounds

- Series A, Apr 11, 2024, $25M — TLV Partners, Morningside, IAG Capital Partners, Sapir Venture Partners, Benon Group Ltd.
- Series A, Nov 8, 2021, $40M — TLV Partners, Morningside, Sapir Venture Partners, Benon Group Ltd.
- Seed, Apr 1, 2020 — E14 Fund

## Investors

- E14 Fund (https://capitalatlas.ai/funds/e14-fund) — Seed
- TLV Partners (https://capitalatlas.ai/funds/tlv-partners) — Series A
- Morningside (https://capitalatlas.ai/funds/morningside) — Series A
- Sapir Venture Partners (https://capitalatlas.ai/funds/sapir-venture-partners) — Series A
- Benon Group Ltd. — Series A
- IAG Capital Partners (https://capitalatlas.ai/funds/iag-capital-partners) — Series A